Part of MLB’s deal with Anthony Bosch is that the league will dismiss the lawsuit it filed against him. It hasn’t done that yet. Which isn’t terribly surprising as MLB is still probably wanting to ensure continued cooperation from him and to ensure that they get something of value from him. The court likely won’t make the league do anything until various deadlines approach that require its attention.
But there are other defendants besides Bosch. One of them is his former colleague who is alleged by MLB to have also given players PEDs. His name is Carlos Acevedo and just this afternoon his latest request to have the lawsuit against him dismissed was denied, so he’s still in MLB’s crosshairs.
Acevedo is an interesting character here. I presume his defense — in addition to some statute of limitations grounds mentioned in the linked article — will be that he had nothing to do with Biogenesis. Which may be technically true. However, Acevedo and Bosch were partners in a predecessor anti-aging clinic before they had a falling out and went their separate ways. And it wasn’t too terribly long ago that this happened. The third partner in that clinic, a guy named Xavier Romero, left with Acevedo. He told the New York Times a couple of months ago that (a) he didn’t do anything with athletes; and (b) Bosch was a wreck and that he was surprised that he’d be able to lure baseball players as clients. The article also noted that Acevedo had a good reputation in the anti-aging community and worked with solid medical companies in the past.
Which makes me wonder about Major League Baseball’s interest in Acevedo. Do they think that he was a source of PEDs to players? If so, you’d think he’d be a better target for cooperation than Bosch, given his apparently more august standing in the world, his greater ability (in Romano’s view, one presumes) to lure high profile clients; and, by extension, his fewer credibility problems. On the other hand, if they don’t think he was involved, this lawsuit, with respect to Acevedo anyway, stinks to high heavens.
While I disagreed with Major League Baseball’s lawsuit when it was filed and still believe it’s the weakest legal sauce imaginable, I don’t think MLB is in the business of harassing truly innocent parties, which is what they’d be doing here if Acevedo didn’t have some sort of involvement in providing drugs to players. Which makes me think that maybe they’re trying to do with Acevedo what they did with Bosch: flip him and get him to talk about players’ drug use. Which suggests that either MLB doesn’t think that it yet has the goods or that it’s being extremely deliberate as it builds its case.
If they do have the goods on the players, though, you’d think they’d quit pursuing Acevedo, right?
From Jon Heyman of CBS Sports comes word that the Orioles “like” free agent starter Yovani Gallardo and “have reached out to him” to gauge his interest in coming to Baltimore and what that might cost.
Gallardo rejected a one-year, $15.8 million qualifying offer from the Rangers earlier this month and so his free agency is tied to draft pick compensation, but that shouldn’t hurt his bottom line all that much.
The 29-year-old right-hander posted a solid 3.42 ERA in 184 1/3 innings (33 starts) this past season for Texas and he pitched well in his one ALDS start.
Heyman reported a few weeks ago that the Diamondbacks are interested, and the Cubs, Blue Jays, and Dodgers were tied to him just ahead of the July 31 trade deadline.
David Price has expressed a desire to return to Toronto, where he finished out the 2015 season, but FOX Sports’ Ken Rosenthal writes Wednesday that the Blue Jays “are not expected to be a major factor in his free agency.”
The teams that should be considered serious suitors, per Rosenthal, are the Cubs, Cardinals, Giants, Dodgers, and Red Sox — all deep-pocketed teams looking to contend in 2016. Money is apparently the issue for the Blue Jays, who are currently owned by Rogers Communications.
Price registered an outstanding 2.45 ERA, 1.076 WHIP, and 225/47 K/BB ratio in 220 1/3 innings (32 starts) this past season between the Tigers and Jays, finishing second in the American League Cy Young Award race behind Dallas Keuchel of the Astros.
The 30-year-old left-hander is probably looking for a six- or seven-year contract worth more than $25 million per season. He is represented by agent Bo McKinnis.
Barry Jackson of the Miami Herald wrote three weeks ago that the Marlins were probably going to explore an extension this winter with second baseman Dee Gordon. And it sounds like those talks are underway.
Via beat writer Joe Frisaro of MLB.com:
As a guest on MLB Network’s “Hot Stove” show Wednesday morning, Gordon confirmed his camp has been in talks with the Marlins regarding a multiyear deal. A source told MLB.com that the discussions are preliminary and have just recently started.
“My agent is doing the talking,” Gordon said on the show. “They’re just keeping me in the loop. I think it’s going pretty well right now. We’ll see how that goes. I’m just playing the waiting game. We’re going to do the right thing.”
The 27-year-old carries three more seasons of salary arbitration, so there’s no real rush to get something done before next spring. Gordon carries quite a bit of leverage after posting a career-best .333/.359/.418 slash line in 145 games this past season for the Fish. He led all major leaguers in hits (205) and stolen bases (58).
Bud Norris has found a home for his attempt at a bounceback season, signing a one-year deal with the Braves. Jon Heyman of CBSSports.com says it’s worth $2.5 million, which is a huge cut from his $8.8 million salary this year.
Norris had established himself as a solid mid-rotation starter from 2009-2014, but had a brutal 2015 season split between the Orioles and Padres with a 6.72 ERA in 83 innings and a late-season move to the bullpen.
In announcing the signing the Braves referred to Norris as a starting pitcher, so joining the rotation for a rebuilding team gives him a chance to get his career back on track with an eye on hitting the open market as a free agent again next offseason. And if he fares well, the Braves could use him to add a prospect or two at the trade deadline.